1. A real‐world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first‐line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United States. Issue 1 (23rd January 2023) Authors: Mato, Anthony; Tang, Boxiong; Azmi, Soraya; Yang, Keri; Han, Yi; Zhang, Xiaowei; Roeker, Lindsey; Wallis, Nicola; Stern, Jennifer C.; Hedrick, Eric; Huang, Jane; Sharman, Jeff P. Journal: EJHaem Issue: Volume 4:Issue 1(2023) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparing treatment satisfaction, adherence, and menstrual symptoms between women using extended-cycle and monthly – cycle birth control pills. (November 2016) Authors: Lee, Lulu K.; Flores, Natalia M.; Micheletti, Marie-Christine; Liebert, Ryan; Weiss, Herman; Tang, Boxiong Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 206(2016:Nov.) Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparing treatment satisfaction, adherence, and menstrual symptoms between women using extended-cycle and monthly – cycle birth control pills. (November 2016) Authors: Lee, Lulu K.; Flores, Natalia M.; Micheletti, Marie-Christine; Liebert, Ryan; Weiss, Herman; Tang, Boxiong Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 206(2016:Nov.) Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of the Affordable Care Act on the Cost of Intrauterine Device Insertion [10N]. (May 2016) Authors: McCarthy, H. Catherine; Howard, Brandon; Eid, Sherrine; Strachan, Gordon; Tang, Boxiong Journal: Obstetrics and gynecology Issue: Volume 127(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy, safety, and health-related quality of life from a global phase 3 study of tislelizumab as second- or third-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): RATIONALE 303. (March 2022) Authors: Zhou, Caicun; Huang, Dingzhi; Yu, Xinmin; Liu, Yunpeng; Fan, Yun; Shu, Yongqian; Ma, Zhiyong; Wang, Ziping; Cheng, Ying; Wang, Jie; Hu, Sheng; Liu, Zhihua; Poddubskaya, Elena; Disel, Umut; Akopov, Audrey; Ma, Yiyuan; Wang, Yan; Li, Songzi; Yu, Cunjing; Barnes, Gisoo Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia. (October 2014) Authors: Pavelka, Karel; Burgos-Vargas, Ruben; Miranda, Pedro; Guzman, Renato; Yen, Jeng-Hsien; Izzi, Mustafa Al; Szekanecz, Zoltan; Tang, Boxiong; Szumski, Annette; Kotak, Sameer; Bananis, Eustratios; Koenig, Andrew S; Mahgoub, Ehab Y; Rahman, Mahboob U Journal: International journal of clinical rheumatology Issue: Volume 9:Number 5(2014) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer. Issue 2 (March 2022) Authors: Lu, Shun; Yu, Yan; Barnes, Gisoo; Qiu, Xiusong; Bao, Yuanyuan; Tang, Boxiong Journal: Cancer journal Issue: Volume 28:Issue 2(2022) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer. Issue 2 (March 2022) Authors: Lu, Shun; Yu, Yan; Barnes, Gisoo; Qiu, Xiusong; Bao, Yuanyuan; Tang, Boxiong Journal: Cancer journal Issue: Volume 28:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia. Issue 4 (2nd April 2016) Authors: Kropf, Patricia; Barnes, Gisoo; Tang, Boxiong; Pathak, Ashutosh; Issa, Jean-Pierre J. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 4(2016:Apr.) Page Start: 935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events. (September 2018) Authors: Bond, T Christopher; Szabo, Erika; Gabriel, Susan; Klastersky, Jean; Tomey, Omar; Mueller, Udo; Schwartzberg, Lee; Tang, Boxiong Journal: Journal of oncology pharmacy practice Issue: Volume 24:Number 6(2018) Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗